GlassScriptPhysician profile
Nicole Wellbaum
NPI 1740544600
$3,483.01
in general payments reported to CMS, 2019-2025
36 companies · $800 in 2025
The $800 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $139 · 2021: $102 · 2022: $493 · 2023: $647 · 2024: $594 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,041.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $595.52 | 2023-2025 | Myfembree |
| Abbvie INC. | $374.86 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $283.35 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $232.55 | 2019-2025 | |
| Novo Nordisk INC | $229.41 | 2019-2025 | Wegovy |
| Astellas Pharma US INC | $167.70 | 2023-2025 | Veozah |
| Organon LLC | $118.63 | 2022-2025 | Jada System, Nexplanon |
| Pfizer INC. | $108.42 | 2019-2024 | |
| Biogen, INC. | $103.09 | 2024-2025 | Zurzuvae |
| Allergan, INC. | $102.77 | 2019-2020 | |
| Hologic Sales and Service, LLC | $100.62 | 2019-2025 | Myosure Tissue Removal Device, Aptima, Thinprep 2000 Processor |
| Millicent US INC | $95.96 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $93.69 | 2022 | |
| Coopersurgical, INC. | $91.68 | 2019-2025 | Endosee, Paragard T 380a, Sos |
| Mylan Pharmaceuticals INC. | $83.15 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $78.41 | 2019-2020 | |
| Evofem Biosciences, INC. | $73.11 | 2023-2025 | Phexxi, Solosec, Phexx |
| Merck Sharp & Dohme LLC | $68.11 | 2019 | |
| Therapeuticsmd, INC. | $59.12 | 2019-2022 | |
| Aspira Women'S Health INC | $56.25 | 2021 | |
| Medtronic, INC. | $44.85 | 2025 | Truclear, Ligasure |
| Shield Therapeutics INC | $33.18 | 2024-2025 | |
| Duchesnay USA Incorporated | $32.98 | 2019 | |
| Olympus America INC. | $30.63 | 2019 | |
| Lsi Solutions INC | $30.59 | 2025 | Fornisee |
| Amag Pharmaceuticals, INC. | $23.14 | 2019-2020 | |
| Agile Therapeutics, INC. | $22.09 | 2022 | |
| Exact Sciences Corporation | $21.56 | 2024 | Cologuard Collection Kit |
| Exeltis, USA INC. | $20.50 | 2019 | |
| Lilly USA, LLC | $19.50 | 2025 | Zepbound |
| Meditrina | $18.25 | 2019 | |
| Teleflex LLC | $17.52 | 2025 | Quikclot |
| Almatica Pharma LLC | $14.07 | 2022 | |
| Dexcom, INC. | $13.77 | 2024 | Dexcom G6 Transmitter |
| Minerva Surgical, INC | $12.33 | 2022 | |
| Davol INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Wellbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.